The polymorphisms of cytokines (e.g., IL-4, IL-6, IL-17, IL-23, INF-γet al.), which have crucial roles in innate immunity, are also related to the risk of CHB, LC, and HCC in our previous studies [3, 57–60]. This evidence concerns the gene IL17A and hepatocellular carcinoma.